垂体后叶素联合酚妥拉明治疗支气管扩张伴大咯血的临床疗效  被引量:5

Clinical effect of pituitrin combined with phentolamine in treating bronchiectasis with massive hemoptysis

在线阅读下载全文

作  者:仓青松 CANG Qing-song(Sheyang County People's Hospital,Sheyang 224300,China)

机构地区:[1]江苏省盐城市射阳县人民医院,224300

出  处:《临床合理用药杂志》2018年第36期1-2,共2页Chinese Journal of Clinical Rational Drug Use

摘  要:目的探讨垂体后叶素联合酚妥拉明治疗支气管扩张伴大咯血的临床疗效。方法选取射阳县人民医院2016—2017年收治的支气管扩张伴大咯血患者68例,采用随机数字表法分为对照组和观察组,各34例。对照组患者采用甲磺酸酚妥拉明注射液治疗,观察组患者在对照组基础上联合垂体后叶素治疗,两组患者均持续治疗7 d。比较两组患者咯血缓解时间及疗程咯血总量、临床疗效。结果观察组患者咯血缓解时间短于对照组,疗程咯血总量少于对照组(P<0.05)。观察组患者总有效率高于对照组(P<0.05)。结论垂体后叶素联合酚妥拉明治疗支气管扩张伴大咯血的临床疗效确切,其可有效缩短患者咯血缓解时间、减少咯血量,提高止血效果。Objective To investigate the clinical effect of pituitrin combined with phentolamine in treating bronchiectasis with massive hemoptysis.Methods A total of 68 cases of bronchiectasis with massive hemoptysis patients were selected from 2016 to 2017 year in Sheyang County People’s Hospital,which were divided into control group and observation group according to random number table,34 cases in each group.The control group was treated with phentolamine mesilate injection,the observation group was treated with pituitrin based on control group,both groups were treated for 7 days.The hemoptysis remission time,total course of hemoptysis and clinical effect were compared between the two groups.Results The observation group of hemoptysis remission time was shorter than control group,total course of hemoptysis was less than control group(P<0.05).The total efficiency rate in observation group was higher than control group(P<0.05).Conclusion Pituitrin combined with phentolamine have an exact clinical effect in treating bronchiectasis with massive hemoptysis,it can more effectively shorten the remission time of hemoptysis,reduce blood volume,and improve the hemostasis effect.

关 键 词:支气管扩张症 大咯血 垂体后叶素 酚妥拉明 治疗结果 

分 类 号:R562.22[医药卫生—呼吸系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象